Profile
Mr. Roy M.
Gonzales was previously employed as a Chief Financial & Accounting Officer by Ventyx Biosciences, Inc., a Vice President-Finance by Landos Biopharma, Inc., and a Vice President-Finance & SEC Reporting by Histogen, Inc. He received his undergraduate degree from Old Dominion University, an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from the University of California, Los Angeles.
Former positions of Roy Gonzales
| Companies | Position | End |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Director of Finance/CFO | 04/03/2026 |
| LANDOS BIOPHARMA, INC. | Corporate Officer/Principal | 01/06/2022 |
| HISTOGEN INC. | Corporate Officer/Principal | 01/09/2021 |
Education of Roy Gonzales
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Roy Gonzales
















